Review
Accepted on 28 Feb 2025
Evolution of nMOFs in Photodynamic Therapy: From Porphyrins to Chlorins and Bacteriochlorins for Better Efficacy
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1533040
Type at least 3 characters
25,546 articles
Articles
Original Research
Accepted on 28 Feb 2025
Effective doses of remimazolam and esketamine combined with remifentanil for endotracheal intubation without muscle relaxants in pediatric patients
in Obstetric and Pediatric Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1558966
Systematic Review
Accepted on 28 Feb 2025
Renal protective effects of vitamin E for drug-induced kidney injury: A systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1461792
Original Research
Accepted on 28 Feb 2025
Interpreting the clinical significance of multiple large-scale mitochondrial DNA deletions (MLSMD) in skeletal muscle tissue in the diagnostic evaluation of primary mitochondrial disease
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1507493
Review
Accepted on 28 Feb 2025
Phytochemical Profiles and Biological Activity of Myrsine africana L.: A Comprehensive Review
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1565656
Original Research
Accepted on 28 Feb 2025
The C-terminal regions of the GLP-1 and GIP receptors are not the key determinant for their differential arrestin recruitment but modulate rate of receptor endocytosis
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1528295
Review
Accepted on 28 Feb 2025
Protein Structure Prediction via Deep Learning: An In-depth Review
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1498662
Original Research
Accepted on 28 Feb 2025
The real-world analysis of adverse events with azacitidine: a pharmacovigilance study based on the FAERS and WHO-VigiAccess databases
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1555838
Original Research
Accepted on 28 Feb 2025
Innovative application of mefloquine and methacycline in combating Tet(X3/X4)-positive Escherichia coli infections
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1542729
Editorial
Accepted on 28 Feb 2025
DRUGS AND METHODS THAT ENHANCE THE ANTI-CANCER EFFICACY OF ARTESUNATE
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1566700
Original Research
Accepted on 28 Feb 2025
The Impact of Phthalates on Asthma and Chronic Obstructive Pulmonary Disease: A Comprehensive Analysis Based on Network Toxicology and Molecular Docking
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1566965
Original Research
Accepted on 28 Feb 2025
Ocular Pharmacokinetics of Intravitreal Conbercept in a Rabbit Model with Retinal Scatter Laser Photocogulation
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1534048
Original Research
Accepted on 28 Feb 2025
Icarisid â…ˇ modulates mitochondrial dynamics for anti-HBV activity
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1544714
Editorial
Accepted on 28 Feb 2025
Editorial on the Research Topic: Metabolic reprogramming in tumors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1583986
Review
Accepted on 28 Feb 2025
Crosstalk between Bile Acids and Gut Microbiota: A Potential Target for Precancerous Lesions of Gastric Cancer
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1533141
Systematic Review
Accepted on 28 Feb 2025
Global Trends in Antimicrobial Resistance of Enterococcus faecium: A Systematic Review and Meta-Analysis of Clinical Isolates
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1505674